Our platform allows users to curate and explore large clinical datasets in collaboration with hospitals, pharmaceutical companies and software developers to identify novel biomarkers and to better understand diseases and therapeutic approaches.
Location: United Kingdom
Employees: 11-50
Total raised: $30.53M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | Playfair C... | playfair.v... |
| 14.12.2021 | Cambridge ... | cambridgea... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 30.07.2026 | Series B | $20M | Guinness V... |
| 22.04.2024 | Series A | $8.5M | - |
| 02.02.2022 | Seed | $2.03M | - |
Mentions in press and media 29
| Date | Title | Description |
| 19.08.2026 | Qureight expands with addition of second site, to accommodate rapid growth and ongoing development of chest Foundation Model | Investment in new premises in London reflects significant milestone in Company’s growth, following $20 million Series B financing Supports rapid scale-up and development of foundational AI imaging model, to improve clinical trial design acr... |
| 03.08.2026 | European tech weekly recap: €878M in weekly deals and key trends from H1 2026 | Last week, we tracked more than 50 tech funding deals worth over €878 million and over 10 exits, M&A transactions, rumours, and related news stories across Europe. 📊 In H1 2026, European tech companies raised €44.1 billion across 1,740 ... |
| 31.07.2026 | AI Agents Invade Supply Chains: Freehand Lands $75M to Revolutionize Procurement | Freehand secured $75 million in new funding, led by Battery Ventures and NewRoad Capital Partners. This capital will scale its autonomous AI agents, revolutionizing enterprise supply chain and procurement. The technology directly tackles im... |
| 30.07.2026 | Qureight Secures $20M for AI-Powered Clinical Trials | Qureight secured $20 million in Series B funding. Molten Ventures led the round, joined by existing investors. This capital fuels Qureight's AI-powered imaging platform. It targets lung and heart clinical trials. The technology accelerates ... |
| 30.07.2026 | Qureight Raises $20M in Series B Funding | Qureight, a Cambridge, UK-based provider of an end-to-end imaging and precision endpoints platform for clinical trials, raised $20M in Series B funding. The round was led by Molten Ventures with participation from Hargreave Hale AIM VCT, XT... |
| 30.07.2026 | Oxane Partners Receives Investment From TA Associates | Oxane Partners, a NYC-based provider of technology-driven solutions for the private credit industry, received a strategic growth investment from TA Associates. The amount of the deal was not disclosed. The company intends to use the funds t... |
| 29.07.2026 | Qureight closes $20 million Series B financing | Round led by Molten Ventures alongside existing investors Hargreave Hale AIM VCT, XTX Ventures, Guinness Ventures, Meltwind, and Ascension Investment will support Qureight’s next-generation AI-powered quantitative imaging platform to furthe... |
| 29.07.2026 | Qureight secures $20M Series B to expand AI-powered imaging platform for clinical trials | Qureight, an end-to-end imaging company that provides enterprise-grade imaging and precision endpoints for clinical trials with a focus on lung and heart disease, today announced it has raised $20 million in a Series B financing, led by Mol... |
| 29.07.2026 | Qureight Raises $20M for AI-powered Lung and Heart Clinical Trials | Qureight just raised $20 million to fix how to read a chest scan. The Cambridge company builds AI imaging tools for lung and heart clinical trials, and its Series B was led by Molten Ventures, with backers Hargreave Hale AIM VCT, XTX Ventur... |
| 29.07.2026 | Freehand Raises $75 Million as AI Agents Take Up Meta and Unilever’s Supply Chains | As enterprises scale, they often run into problems in manual supply-chain spend management and financial leakage. Freehand raises $75 million to put AI agents in supply chains to solve this problem. The round was co-led by Battery Ventures ... |
Show more